Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Sjogren’s syndrome
Is there any role for immunosuppressive therapy in patients with primary Sjogren's disease with severe pulmonary artery hypertension without ILD findings?
Related Questions
How long are cholinergic agonists such as pilocarpine required to be held before doing tear assessments (ocular scoring and Schirmer’s) and sialography/salivary collection?
How would you treat chorea in a patient with Sjögren’s syndrome and positive beta 2 glycoprotein I antibodies?
How do you approach hypocomplementemia in Sjogren’s without features of lymphoma?
Do you always perform salivary gland biopsy to confirm the diagnosis In patients with suspected seronegative Sjogren's syndrome?
In patients with sicca symptoms and positive SSA/SSB how often do you perform other diagnostic testing such as salivary gland ultrasound, biopsy, Shirmers, ocular staining, stimulated salivary flow, etc?
What is your initial treatment paradigm for someone with both CNS and peripheral neurologic Sjogren’s?
Do you use hydroxychloroquine for patients with asymptomatic primary Sjogren syndrome to treat hypergammaglobulinemia without other concerning features?
What is your treatment approach to neurological Sjogrens disease with both peripheral neuropathy and transverse myelitis?
Would you modify your treatment approach for treating an HPV-positive head and neck cancer in a patient with symptomatic Sjogren's?
How do you approach the timing of DMARD initiation in patients with active RA who are on treatment for latent TB?
